CTC (Chicago Trading Company)’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-11,200
Closed -$1.11M 226
2024
Q4
$1.11M Buy
11,200
+11,049
+7,317% +$1.14M ﹤0.01% 243
2024
Q3
$1.71M Sell
151
-212
-58% -$25.2K ﹤0.01% 233
2024
Q2
$4.49M Sell
363
-1,653
-82% -$213K ﹤0.01% 225
2024
Q1
$26.6M Sell
2,016
-153
-7% -$18.9K 0.01% 156
2023
Q4
$23.6M Buy
2,169
+152
+8% +$15.8K 0.01% 182
2023
Q3
$20.8M Sell
2,017
-2,230
-53% -$240K 0.01% 182
2023
Q2
$49M Buy
4,247
+935
+28% +$106K 0.03% 149
2023
Q1
$35.1M Buy
3,312
+1,358
+69% +$147K 0.02% 168
2022
Q4
$21.7M Sell
1,954
-1,247
-39% -$127K 0.02% 180
2022
Q3
$27.5M Sell
3,201
-903
-22% -$80.6K 0.02% 178
2022
Q2
$37.4M Buy
4,104
+1,380
+51% +$122K 0.02% 160
2022
Q1
$22.3M Buy
2,724
+661
+32% +$52.1K 0.01% 215
2021
Q4
$15.8M Buy
+2,063
New +$164K 0.01% 181

Other funds holding MRK

CTC (Chicago Trading Company)'s MRK Position: Q1 2025 in Review

CTC (Chicago Trading Company) sold out of Merck (MRK) in Q1 2025, closing a stake of 14,148 shares — an estimated $1.41M sold.

CTC (Chicago Trading Company) first reported a position in MRK in Q4 2021 and held it in 9 quarters. The position peaked at $27.1M in Q4 2021. 3,449 funds tracked by Wall St. Rank hold MRK as of Q1 2025.

  • CTC (Chicago Trading Company) reported no remaining Merck position as of Q1 2025 after selling out during the quarter.
  • CTC (Chicago Trading Company) sold 14,148 Merck shares in Q1 2025, an estimated $1.41M.
  • CTC (Chicago Trading Company) first reported a position in Merck in Q4 2021 and held it in 9 quarters.
  • CTC (Chicago Trading Company)'s Merck position peaked at $27.1M in Q4 2021.
  • 3,449 funds tracked by Wall St. Rank held Merck as of Q1 2025.

Based on CTC (Chicago Trading Company)'s 13F filing for Q1 2025, filed 16 May 2025.